0001213900-20-023899.txt : 20200826 0001213900-20-023899.hdr.sgml : 20200826 20200826181605 ACCESSION NUMBER: 0001213900-20-023899 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200824 FILED AS OF DATE: 20200826 DATE AS OF CHANGE: 20200826 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fairbairn Malcolm CENTRAL INDEX KEY: 0001317314 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39102 FILM NUMBER: 201138421 MAIL ADDRESS: STREET 1: C/O ASCEND CAPITAL, LLC STREET 2: 4 ORINDA WAY, SUITE 200-C CITY: ORINDA STATE: CA ZIP: 94563 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TFF Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001733413 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 824344737 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2600 VIA FORTUNA, SUITE 360 CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: 737-802-1973 MAIL ADDRESS: STREET 1: 2600 VIA FORTUNA, SUITE 360 CITY: AUSTIN STATE: TX ZIP: 78746 4 1 ownership.xml X0306 4 2020-08-24 0 0001733413 TFF Pharmaceuticals, Inc. TFFP 0001317314 Fairbairn Malcolm 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 1 0 0 0 Stock Options (Right to Buy) 13.65 2020-08-24 4 A 0 13200 0.00 A Common Stock 13200 105455 D Each Option shall vest and first become exercisable as follows: one-quarter of the Option shall vest and first become exercisable on August 24, 2021 and the remainder of the Option shall vest and first become exercisable in 12 equal quarterly installments commencing on November 24, 2021. /s/ Malcolm P. Fairbairn 2020-08-26